The Aug 10 deadline is approaching fast! Help shape the future of cancer care by submitting your topic suggestions or new clinical evidence for ASCO guidelines. Your expertise drives the oncology community forward. Submit today: https://bit.ly/3ZK61Wi

Progress against cancer is built over decades. As a GI medical oncologist, Dr. S. M. Qasim Hussaini knows that continued federal research funding today is critical in order to develop the breakthroughs his patients will need tomorrow. Learn more: https://bit.ly/4x8IEnr #ASCOAdvocacy

Maximize your time with an Officially Licensed Best of ASCO® meeting! Discover the year's most significant scientific findings in a condensed, high-impact format that enables you to integrate the latest advances to enhance patient care. Learn more: https://bit.ly/4fHn7vd

We join the oncology community in mourning the passing of Dr. Gary R. Morrow, whose groundbreaking research leading to the development of effective anti-emetic drugs was voted as one of the top five cancer advances in the history of the field by ASCO members. Read more: https://bit.ly/3RH7FXN

Don’t just watch the future of GI oncology unfold—help shape it. Submit your abstract to #GI27, the premier global event for specialized GI cancer research. Submit now at: https://bit.ly/4wBGxbS Co-sponsors: @amergastroassn.bsky.social, @astro-org.bsky.social & @socsurgonc.bsky.social

Updated recommendations support entrectinib, larotrectinib, & repotrectinib for NTRK fusion-positive solid tumors. Data from the TRIDENT-1 trial highlights repotrectinib's 59% cORR in TKI-naïve patients, along with strong CNS activity. Read the article: https://bit.ly/4pQ5Lkw

Congratulations to our Past President Dr. Lori J. Pierce on being named the Allen S. Lichter Distinguished University Professor of Radiation Oncology at @umich.edu! Her pioneering work has helped advance safe, effective radiotherapy and shape standards of care for early-stage #BreastCancer.

Medical School’s Lori J. Pierce, MD, named Distinguished University Professor

Medical School professor Lori J. Pierce, M.D., is one of six U-M faculty members recognized for their outstanding teaching and service with one of the university’s most prestigious honors: the Disting...

medschool.umich.edu

For Dr. Heloisa Soares, protecting federal research funding is about supporting the talented researchers & physician-scientists who accelerate the pace of discovery & deliver new options to patients who are counting on the next breakthrough. Learn more: https://bit.ly/45idr5k #ASCOAdvocacy​

🎙Dr. Sumanta K. Pal of @cityofhope.bsky.social and Dr. Atul Batra discuss how to translate groundbreaking #ASCO26 Plenary results into global practice, using India's health care landscape as a blueprint, on the latest episode of the #ASCODailyNews Podcast: https://bit.ly/4bafGeA

Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: https://bit.ly/4x3SMOB

Dr. Pedro Barata of University Hospitals Seidman Cancer Center and Dr. Giuseppe Curigliano of @myesmo.bsky.social discuss the next era of ADCs and challenges with sequencing, target selection, and resistance on the latest episode of #BytheBook Podcast: https://bit.ly/4ysCRdX. #ASCOEdBook

Don't miss your chance to influence the future of cancer care. Submit your topic suggestions or new evidence for an existing guideline by August 10 and help us develop relevant and impactful resources for the oncology community. Submit now: https://bit.ly/3ZK61Wi

Throughout her career, Dr. Jasmine Kamboj has seen decades of federally funded research translate to longer and better quality of life. That’s why she’s advocating to ensure future patients benefit from the next generation of breakthroughs. Learn more: https://bit.ly/4fsUJNm #ASCOAdvocacy​

Dr. Fiorella Iglesias Cardenas provides helpful guidance for early-career investigators looking to intentionally and meaningfully engage with the National Clinical Trials Network. Read more: https://bit.ly/4pkfkYu #ASCOConnection

The 2027 Medicare Physician Fee Schedule and Quality Payment Program proposed rule is out now. We’re analyzing the impact on cancer care, but an initial estimate shows a 1.5% overall reimbursement cut for hematology/oncology Learn more: https://bit.ly/456jTfH #ASCOAdvocacy

We welcome Dr. Neal Meropol as the new TAPUR Study PI. Dr. Meropol aims to expand clinical trial access, leverage global data for rare cancers, & support professional development for early-career oncologists. Read more about his vision: https://bit.ly/4wLl93X #ASCOConnection

The draft guideline recommendations for “Initial Treatment for Chronic Lymphocytic Leukemia" are open for comments. Please review and submit your comments to us by July 29 to help shape final recommendations: https://bit.ly/4fesp0O

Want to directly influence the development of critical oncology resources? Now is your chance. Submit your guideline topic suggestions or new evidence before the August 10 deadline. Share your expertise here: https://bit.ly/3ZK61Wi

Drs. Kelsey Natsuhara, Karan Sood, and Paramveer Singh reflect on their experiences as early-career oncologists across three distinct practice settings—community, academic, and international—and offer practical insights for trainees. Read more: https://bit.ly/4vydCnX

Last call to nominate for the 2027 ASCO Special Awards! Earn up to 2 FASCO points and recognize a deserving colleague before the July 15, deadline. Submit here: https://bit.ly/3TbZx1T

#ASCOAdvocacy is calling on OMB to revise & delay a proposed rule that would undermine merit-review research, devastate public scientific conversations, & allow agencies to terminate grants mid-stream. Full statement: https://bit.ly/4wx30q8

Expand your network, collaborate with regional peers, & develop practical leadership skills in our LDP: Asia Pacific program. Review eligibility requirements & apply for the 2027 program by August 17, 2026: https://bit.ly/4vX6L8s

“Getting prior authorization reform at the federal level would be so impactful…” The #SeniorsAct is just that, a bipartisan bill that would help #FixPriorAuth for pts across the country. Write to Congress and tell them to act NOW: https://bit.ly/3R9nDd8 #ASCOAdvocacy

The draft guideline recommendations for "Integration of Patient-Reported Outcomes in the Routine Care of Adults Undergoing Systemic Treatment for Cancer" are now available. Help us refine these standards of care. Submit your feedback to us by July 22: https://bit.ly/4h3Xkzx

The draft guideline protocol for "Vaccination of Adults With Cancer" is now open for comments. Please review and submit your comments by July 22 to help shape final recommendations: https://bit.ly/44SIJQ5

Dr. Sumanta K. Pal of @cityofhope.bsky.social and Dr. Roselle De Guzman discuss key studies on liquid biopsy, AI, and other highlights from #ASCOBT26 on the latest episode of the #ASCODailyNews Podcast: https://bit.ly/4eXr6TO

Ready to swap the standard #MedEd textbook for next-gen leadership? The 2027-28 ASCO LDP: Education Scholars is looking for its next cohort. This program is about building a community, learning leadership skills, and advancing medical education. Apply by Sept 14: https://bit.ly/4eO7mDv

LAST CALL: The deadline for the YIA in Pediatric Brain Tumors is July 15. If you're an investigator looking to advance your research career, apply for this @conquercancer.bsky.social Young Investigator Award by July 15: https://bit.ly/3R06Glm

🎆 The 2026 ASCO-SEP edition has launched! Whether you’re studying for the boards or looking to stay current, get the knowledge & confidence to excel in your career w/ ASCO-SEP. 20% off for ASCO members; additional discounts available. Subscribe today: https://bit.ly/3SOGJ8S

This year we are debuting two new Special Awards celebrating expanded access to care: The Community Legacy Award & Cancer Care Impact Award. Let's honor those driving oncology forward. Nominations close July 15: https://bit.ly/4p0d08V